Denali Therapeutics Inc. (DNLI) PT Lowered to $50 at Evercore ISI
Tweet
Share
E-mailGet Alerts DNLI Hot Sheet
Price: $24.35 -0.2%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Join SI Premium – FREE
Evercore ISI analyst Joshua Schimmer lowered the price target on Denali Therapeutics Inc. (NASDAQ: DNLI) to $50.00 (from $80.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Genesis Minerals Ltd (GMD:AU) PT Lowered to AUD8.60 at Citi
- Baird Downgrades Ameresco (AMRC) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
